| 2024/04/22 22:00:00 | |
|---|---|
| Price | |
| 5.05 USD | |
| Difference | 1.20% (0.06) |
General attributes
| ISIN | CA05156V1022 |
| Symbol | AUPH |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 686 EUR |
| Benchmark | S&P/TSX 60 INDEX |
Market data
| Bid (Bid size) | 5.02 USD (400) |
| Ask (Ask size) | 5.16 USD (100) |
| Open | 4.98 USD |
| High | 5.06 USD |
| Low | 4.92 USD |
| Close (prev. day) | 4.99 USD |
| VWAP | 5.007411 USD |
| Volume (pcs) | 1,167,172 |
| Trading volume | 5,846,236.72 |
| Number of trades | 6,682 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/22 22:00:00 | |
|---|---|
| Price | |
| 5.05 USD | |
| Difference | 1.20% (0.06) |
General attributes
| ISIN | CA05156V1022 |
| Symbol | AUPH |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 686 EUR |
| Benchmark | S&P/TSX 60 INDEX |
Market data
| Bid (Bid size) | 5.02 USD (400) |
| Ask (Ask size) | 5.16 USD (100) |
| Open | 4.98 USD |
| High | 5.06 USD |
| Low | 4.92 USD |
| Close (prev. day) | 4.99 USD |
| VWAP | 5.007411 USD |
| Volume (pcs) | 1,167,172 |
| Trading volume | 5,846,236.72 |
| Number of trades | 6,682 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -32.67% | -52.85% | -59.98% |
| Perf (abs.) | -2.45 | -5.66 | -7.57 |
| Beta | 1.50 | 1.16 | 1.60 |
| Volatility | 63.96 | 57.26 | 82.36 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 4.95 USD (1,368,008) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 5.08 USD (1,445,192) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 7.01 USD (2,145,698) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 8.45 USD (2,177,552) |
| YTD High | date | 9.43 USD (2024/01/10) |
| YTD Low | date | 4.71 USD (2024/04/18) |
| 52 Weeks High | date | 12.43 USD (2023/07/28) |
| 52 Weeks Low | date | 4.71 USD (2024/04/18) |
All listings for AURINIA PHARMACEUTICALS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/04/22 | 22:02 | 4.737 EUR | 0.00 | 1 |
| Stuttgart | 2024/04/23 | 08:06 | 4.694 EUR | 0.00 | 1 |
| Nasdaq | 2024/04/22 | 22:00 | 5.05 USD | 5.85 | 6,682 |
| Munich | 2024/04/23 | 08:04 | 4.691 EUR | 0.00 | 1 |
| London Stock Exchange | 2021/02/05 | 16:52 | 19.6090 CAD | 0.00 | 1 |
| Frankfurt | 2024/04/23 | 09:17 | 4.598 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/23 | 12:32 | 4.691 EUR | 0.00 | 3 |
| Berlin | 2024/04/23 | 08:13 | 4.695 EUR | 0.00 | 1 |
Company Profile
| - |
Board of directors
| Daniel Billen | Chairman of Supervisory Board |
| Brinda Balakrishnan | Member of Supervisory Board |
| David Jaynee | Member of Supervisory Board |
| Karen Smith | Member of Supervisory Board |
| Robert Foster | Member of Supervisory Board |
| Jeffrey Bailey | Member of Supervisory Board |
| Jill Leversage | Member of Supervisory Board |
| R. MacKay-Dunn | Member of Supervisory Board |